| Unique ID issued by UMIN | UMIN000002717 |
|---|---|
| Receipt number | R000003135 |
| Scientific Title | Study of low-responder to Tafluprost ophthalmic solution and Latanoprost ophthalmic solution |
| Date of disclosure of the study information | 2010/01/01 |
| Last modified on | 2011/05/06 10:50:06 |
Study of low-responder to Tafluprost ophthalmic solution and Latanoprost ophthalmic solution
Study of low-responder to Tafluprost ophthalmic solution and Latanoprost ophthalmic solution
Study of low-responder to Tafluprost ophthalmic solution and Latanoprost ophthalmic solution
Study of low-responder to Tafluprost ophthalmic solution and Latanoprost ophthalmic solution
| Japan |
Glaucoma Ocular Hypertension
| Ophthalmology |
Others
NO
To investigate effects of Taflurost and Latanoprost on intraocular pressure lowering rate, low-responder to each ophthalmic solution and safety in glaucoma and ocular hypertension in randomized, open-labeled, crossover, study.
Efficacy
Exploratory
Efficacy: Intraocular Pressure Lowering rate
Intraocular Pressure
Safety
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
YES
Numbered container method
2
Treatment
| Medicine |
After more than 4weeks of washout period, instill Tafluprost for 8 weeks. Then 4 weeks of second washout period, instill Latanoprost for 8weeks.
After more than 4weeks of washout period, instill Latanoprost for 8 weeks. Then 4 weeks of second washout period, instill Tafluprost for 8weeks.
| 20 | years-old | <= |
| Not applicable |
Male and Female
1) Diagnosed with primary open angle glaucoma or ocular hypertension, and being receiving monotherapy or no-treatment.
2) Intraocular pressure is more than 16 mmHg without treatment or more than 13 mmHg with monotherapy treatment.
3) Over 20 years old on the date of agreement.
4) Both male and female
5) Outpatient care
6) Subjects whose agreement was shown by him/herself.
1) Having any hypersensitivity to test drugs.
2) Having severe visual field defect (HFA <-15dB)
3) Having absolute scotoma within 5 degrees in the center of the visual field.
4) Having any corneal abnormality or other condition preventing reliable applanation tonometry.
5) Having history of glaucoma surgery.
6) Having history of cataract surgery within 1 year.
7) Having history of refractive surgery.
8) Presence of any external ocular disease, inflammation or infection of the eye and/or eyelids.
9) Subjects need to be treated with corticosteroid during study period.
10) Pregnant subjects and subjects suspected of being pregnant
11) Subjects investigators declare ineligible for any sound medical reason
100
| 1st name | |
| Middle name | |
| Last name | Masanori Hangai |
Kyoto University Hospital
Department of Ophthalmology and visual sciences
54 Kawara-cho Seigoin Sakyuo-ku Kyoto
| 1st name | |
| Middle name | |
| Last name | Atsushi Nonaka |
Kyoto University Hospital
Department of Ophthalmology and visual sciences
Kyoto University Hospital
Department of Ophthalmology and visual sciences
None
Self funding
NO
| 2010 | Year | 01 | Month | 01 | Day |
Unpublished
Terminated
| 2009 | Year | 09 | Month | 01 | Day |
| 2010 | Year | 01 | Month | 01 | Day |
| 2010 | Year | 12 | Month | 01 | Day |
| 2010 | Year | 12 | Month | 01 | Day |
| 2010 | Year | 12 | Month | 01 | Day |
| 2011 | Year | 03 | Month | 01 | Day |
| 2009 | Year | 11 | Month | 05 | Day |
| 2011 | Year | 05 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003135